Lamivudine reverses severe acute hepatitis B and pancytopenia after renal transplantation: a case report.
Transplant Proc
; 38(9): 3125-7, 2006 Nov.
Article
en En
| MEDLINE
| ID: mdl-17112916
ABSTRACT
Pancytopenia is rare after acute hepatitis B infection. The use of lamivudine in the treatment of acute hepatitis B-associated pancytopenia in renal transplant recipients has not been documented. Herein we reported a 21-year-old woman who was infected with acute hepatitis B 6 months after renal transplantation, a condition complicated by pancytopenia. Lamivudine reversed the acute hepatitis in 1 month and the pancytopenia after 3 months, without a change in renal function. Lamivudine was maintained for 2 years without a hepatitis flare-up after 4 years.
Search on Google
Banco de datos:
MEDLINE
Asunto principal:
Pancitopenia
/
Trasplante de Riñón
/
Lamivudine
/
Hepatitis B
Límite:
Adult
/
Female
/
Humans
Idioma:
En
Año:
2006
Tipo del documento:
Article